EGFR激活和 conformational "融合":一个新兴的来自癌症突变的菌模型
1Protein Dynamics and Mutation Lab, Department of Oncology-Pathology, Karolinska Institute, Sweden.
Journal of molecular biology
|October 24, 2025
概括
脑质母细胞瘤 (GBM) 中的表皮生长因子受体 (EGFR) 突变涉及外皮,与肺癌突变不同. 这种灵活性通过揭示中间状态来解释GBM中共享的药物反应.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 结构生物学 结构生物学
背景情况:
- 表皮生长因子受体 (EGFR) 是一个关键的瘤基因,但由于有限的全长结构数据和固有的灵活性,其激活机制仍然不完全理解.
- EGFR突变表现出组织特异性模式,并影响药物敏感性,特别是在肺癌和质母细胞瘤 (GBM) 中.
- 肺癌突变主要影响着激酶域,而GBM突变通常向生体域 (ECD),但具有相同的药物反应特征.
研究的目的:
- 阐明EGFR细胞外和细胞内域之间的合机制,重点关注在GBM中观察到的中间ectodomain过渡状态.
- 通过分析ectodomain突变的结构影响来解释GBM中共享的药物反应.
主要方法:
- 汇总了EGFR现有的结构和突变数据.
- 对抗体检测和分子模拟的分析,以表征一种中间ECD状态.
- 比较GBM和肺癌突变概况及其对受体激活的影响.
主要成果:
- 确定了一种中间的ECD过渡状态,涉及关键片段的灵活旋转,并与GBM突变联系在一起,包括常见的EGFRvIII删除.
- GBM ECD 中的收误解和删除突变针对相同的灵活区域,这表明有一个共同的机制.
- 一个神秘的表位与这种中间状态有关,为GBM中共享的药物反应提供了分子基础.
结论:
- EGFR激活是由一个全质机制调节的,在这种机制中,细胞外和细胞内域被合成预先形成的二次体,而ECD刚性阻止了激酶激活.
- GBM 突变通过使 ECD 灵活而绕过这种硬质封锁,而肺癌突变直接增强激酶活性,导致明显的药物敏感性.
- 了解EGFRectodomain在GBM病原和药物反应中的作用,对于开发向疗法至关重要.
更多相关视频
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.6K
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.5K
相关概念视频
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
